Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 1902Glioblastoma 1795Glioma 1127Central Nervous System Neoplasms 599Astrocytoma 593Neuroblastoma 552Gliosarcoma 465Oligodendroglioma 363Neoplasms 312Breast Neoplasms 273Medulloblastoma 272Carcinoma, Non-Small-Cell Lung 226Recurrence 199Sarcoma 183Neoplasm Metastasis 183Melanoma 181Meningioma 177Ependymoma 175Lung Neoplasms 157Lymphoma 133Osteosarcoma 126Meningeal Carcinomatosis 126Neurofibromatosis 1 114Wilms Tumor 111Ovarian Neoplasms 110Diffuse Intrinsic Pontine Glioma 105Precursor Cell Lymphoblastic Leukemia-Lymphoma 103Rhabdomyosarcoma 100Lymphoma, Non-Hodgkin 96Burkitt Lymphoma 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Schwannomatosis × CNS × Clear all
NCT03406208 2025-12-24

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

Massachusetts General Hospital

Phase NA Completed
228 enrolled
CNS

Schwannomatosis, Behavior, Neurofibromatosis 1, Neurofibromatosis 2, Neurofibromatoses

NCT02298270 2016-06-23

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

Massachusetts General Hospital

Phase NA Completed
65 enrolled
CNS

Schwannomatosis, Neurofibromatosis 1, Neurofibromatosis 2, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡